Louisiana 2025 Regular Session

Louisiana Senate Bill SB78

Introduced
4/2/25  
Refer
4/2/25  
Refer
4/14/25  
Report Pass
4/15/25  
Engrossed
4/23/25  
Refer
4/24/25  
Report Pass
5/20/25  
Enrolled
6/4/25  
Chaptered
6/8/25  

Caption

Provides relative to drug paraphernalia. (gov sig)

Summary

SB 78 amends Louisiana’s drug paraphernalia law to carve out an exemption for rapid fentanyl test strips and other testing equipment or devices used solely to determine whether a substance contains fentanyl, fentanyl analogues, or other controlled dangerous substances or harmful chemical compounds. Under the bill, these items are not considered drug paraphernalia so long as they are not used to facilitate the manufacture or distribution of controlled substances in violation of existing drug laws. The measure is aimed at reducing legal barriers to fentanyl testing tools that can help identify dangerous substances and prevent overdose or poisoning. It updates R.S. 40:1021(B), which defines drug paraphernalia, and leaves intact the prohibition on using such equipment to support illegal drug manufacturing or distribution. The act becomes effective upon gubernatorial signature or through the normal constitutional process if not signed.

Impact

SB 78 narrows the scope of Louisiana’s definition of drug paraphernalia by expressly excluding rapid fentanyl test strips and similar substance-testing devices from that category. This change affects law enforcement, prosecutors, harm-reduction programs, healthcare providers, and individuals who possess or distribute fentanyl testing tools for safety purposes. It does not legalize controlled substances or remove penalties for drug manufacture or distribution; rather, it creates a statutory safe harbor for testing devices used to detect dangerous substances.

Sentiment

The bill appears to have broad bipartisan support and little visible opposition. It passed the Senate 37-0, the House 96-0, and the Senate concur vote 37-0, indicating unanimous or near-unanimous agreement in both chambers. The lack of committee transcript material also suggests the measure was not especially controversial in the legislative process.

Contention

The main policy issue is the balance between harm reduction and drug enforcement. Supporters of the exemption are likely focused on overdose prevention and public safety by making fentanyl test strips more accessible, while any potential concern would be that such devices could be viewed as facilitating drug use or could be misused in connection with illegal drug activity. The bill addresses that concern by limiting the exemption to devices used solely for testing and by preserving liability where the equipment is used to aid manufacture or distribution of controlled substances.

Companion Bills

No companion bills found.

Previously Filed As

LA SB9

Provides relative to ranked-choice voting and instant runoff voting. (Item #10)(gov sig) (EG NO IMPACT See Note)

LA HB5

Provides relative to the election districts for members of congress (Item #1) (OR INCREASE GF EX See Note)

LA HB14

Provides relative to the election districts for members of congress (Item #1) (EG INCREASE GF EX See Note)

LA HB2

Provides relative to the election districts for members of congress (Item #1) (OR INCREASE GF EX See Note)

LA SB10

Provides for redistricting of Louisiana congressional districts. (Item #1)(See Act) (OR INCREASE GF EX See Note)

LA HB19

Provides relative to the election districts for members of congress (Item #1) (OR INCREASE GF EX See Note)

LA HB7

Provides relative to supreme court districts (Item #3) (OR INCREASE GF EX See Note)

LA HB10

Provides relative to filing financial disclosure statements after qualifying for office (Item #8)

LA SB4

Provides for redistricting of Louisiana congressional districts. (Item #1)(See Act) (OR INCREASE GF EX See Note)

LA HB4

Provides relative to the assessment of penalties for failure to timely file required reports (Item #8) (OR SEE FISC NOTE GF RV)

Similar Bills

No similar bills found.